Aerami Therapeutics

About:

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.

Twitter/X: AeramiTx

Top Investors: SternAegis, Molex Ventures, John Patton

Description:

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.

Total Funding Amount:

$134M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)aerami.com

Founders:

John S. Patton

Number of Employees:

11-50

Last Funding Date:

2022-09-20

IPO Status:

Private

Industries: